Naturis Cosmetics funding makes headlines as Naturis Cosmetics, a Jammu-based beauty and personal care contract manufacturer, raises ₹33.74 Cr (approximately USD 3.5 million) in its maiden institutional Seed round, as publicly reported on 2026-07-13. The round is led by Sharrp Ventures, with participation from Mirabilis Investment Trust. This marks the first time the fully promoter-owned company has brought in institutional capital, signalling a new chapter in its growth story.
Quick Highlights
- Founder & CEO: Rahul Tandon
- Lead Investor: Sharrp Ventures
- Participating Investor: Mirabilis Investment Trust
- Investor Background: Sharrp Ventures is the single-family office of the Harsh Mariwala family, founded in 2014 and headquartered in Mumbai; it primarily backs Consumer, Retail, and Consumer Goods companies at Seed and Series A stages
- Headquarters: Jammu, Jammu & Kashmir, India
- Announcement Date: 13 July 2026
Funding Breakdown
Use of Funds
As publicly reported, the fresh capital is expected to be directed towards expanding manufacturing capacity, upgrading technology, and strengthening Naturis Cosmetics’ R&D and formulation capabilities. The company operates a 100,000-square-foot facility in Jammu that houses its production unit, R&D laboratory, QA/QC laboratory, and corporate office; the new funds are anticipated to support adding production lines, enhancing automation, and deepening quality assurance systems to meet rising demand from beauty and personal care brands.
Funding Timeline
Founded in 2011, Naturis Cosmetics operated as a fully promoter-owned entity until this maiden institutional round. The ₹33.74 Cr tranche — with Sharrp Ventures contributing ₹22.5 Cr and Mirabilis Investment Trust contributing ₹11.25 Cr — is structured via the issuance of 12,784 preference shares at an issue price of ₹26,400 each, as approved by a special board resolution filed with the Registrar of Companies. As publicly reported, this tranche may form part of a broader fundraising effort, with earlier reports indicating the company had been in discussions to raise between ₹80 Cr and ₹100 Cr in total.
Expansion Plans
As publicly reported, Naturis Cosmetics is pursuing possible multi-location manufacturing hubs as a longer-term growth opportunity, leveraging institutional backing from Sharrp Ventures and Mirabilis Investment Trust to professionalize operations and improve governance. The company currently distributes its private-label and custom formulations across India as well as in South East Asia, the Middle East, Europe, and the US, and the institutional round is expected to enable it to pursue more structured expansion going forward.
Significance
This Naturis Cosmetics funding round is notable not just for its size, but for what it represents: a shift in investor attention from front-end beauty brands to the back-end contract manufacturing ecosystem that powers them. Naturis reported a 40% year-on-year increase in operating revenue to ₹154 Cr in FY25 — up from ₹110 Cr in FY24 — while remaining profitable with a net profit of ₹12 Cr, demonstrating that institutional interest is backed by strong underlying business fundamentals. By converting from a fully promoter-owned entity to an institutionally backed platform, Naturis gains both growth capital and the strategic credibility to deepen client relationships with marquee brands such as Nykaa, Plum, Purplle, Bare Anatomy, and Ustraa. For the broader Indian beauty contract manufacturing sector, this deal signals that investors are increasingly willing to back the infrastructure layer of the beauty economy, not just the brands sitting on top of it.
These details have been verified against multiple publicly available reports as of 2026-07-13.
Stay updated with the latest startup funding news on The Courtroom.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
